New (DNA-based) ways of drugs discovery render more (potential) medications for ever more personalized medicines – It impacts their organizational and marketing substantially.
How is the pharmaceutical industry going to support patients effectively, when numbers of targeted patients appear to fall because of (the need of) individualization by personalized medicine?